Company Filing History:
Years Active: 2007-2010
Title: Innovations by Sharon Anne Jackson
Introduction
Sharon Anne Jackson is a prominent inventor based in Whitehouse Station, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system disorders. With a total of five patents to her name, her work focuses on developing compounds that selectively bind to dopamine receptors.
Latest Patents
One of her latest patents involves heterocyclic substituted carbonyl derivatives that display selective binding to dopamine receptors. This invention relates to a method for treating various central nervous system disorders associated with dopamine receptor activity. The disorders that may be treated include psychotic disorders, substance dependence, substance abuse, dyskinetic disorders such as Parkinson's disease, dementia, anxiety disorders, sleep disorders, circadian rhythm disorders, and mood disorders. Additionally, the invention encompasses processes for preparing these compounds and methods for using them as imaging agents for dopamine receptors. Another significant patent focuses on heterocyclic amide derivatives that also exhibit selective binding to dopamine receptors, further contributing to the treatment of the aforementioned disorders.
Career Highlights
Sharon Anne Jackson is currently employed at Aventis Pharmaceuticals Inc., where she continues to innovate and develop new therapeutic solutions. Her work has been instrumental in advancing the understanding and treatment of complex neurological conditions.
Collaborations
Some of her notable coworkers include Thaddeus Nieduzak and James Hendrix, who have collaborated with her on various projects within the pharmaceutical industry.
Conclusion
Sharon Anne Jackson's contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system disorders, highlight her innovative spirit and dedication to improving patient outcomes. Her patents reflect a commitment to advancing medical science and enhancing therapeutic options for patients in need.